Study: Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
3 Dec, 2018 | 23:40h | UTCSee also: ASH 2018: Updated Analysis of JULIET Trial: Tisagenlecleucel in Relapsed or Refractory DLBCL – The ASCO Post (free)
See also: ASH 2018: Updated Analysis of JULIET Trial: Tisagenlecleucel in Relapsed or Refractory DLBCL – The ASCO Post (free)